After False Advertising Accusation, EpicGenetics Halts 2 Blood Test Sales
Also in the news, gene-editing startup Tome Biosciences; insights into near-death experiences from psychedelics; the cost of Eisai and Biogen's Alzheimer's drug Leqembi; and more.